Cancer  	Cancer  	 NN	B-NP
gene  	gene  	 NN	I-NP
therapy  	therapy  	 NN	I-NP
with  	with  	 IN	O
oncolytic  	oncolytic  	 JJ	B-NP
adenoviruses  	adenoviruses  	 JJ	I-NP
Metastatic  	Metastatic  	 JJ	I-NP
cancer  	cancer  	 NN	I-NP
remains  	remains  	 VBZ	O
difficult  	difficult  	 JJ	O
to  	to  	 TO	O
treat  	treat  	 VB	O
effectively  	effectively  	 RB	O
and  	and  	 CC	O
treatments  	treatments  	 NNS	O
are  	are  	 VBP	O
in  	in  	 IN	O
most  	most  	 JJS	O
cases  	cases  	 NNS	O
not  	not  	 RB	O
curative  	curative  	 VBN	B-NP
despite  	despite  	 IN	O
significant  	significant  	 JJ	O
side  	side  	 NN	B-NP
effects 	effects 	 NNS	I-NP
.  	.  	 .	O
Novel 	Novel 	 NN	O
,  	,  	 ,	O
targeted  	targeted  	 VBN	B-NP
approaches  	approaches  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
gene  	gene  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
hold  	hold  	 NN	I-NP
promise  	promise  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
various  	various  	 JJ	O
tumor  	tumor  	 NN	B-NP
types 	types 	 NNS	I-NP
.  	.  	 .	O
Among  	Among  	 IN	O
the  	the  	 DT	O
most  	most  	 RBS	O
promising  	promising  	 JJ	O
cancer  	cancer  	 NN	B-NP
gene  	gene  	 NN	I-NP
therapy  	therapy  	 NN	I-NP
approaches  	approaches  	 NNS	I-NP
are  	are  	 VBP	O
oncolytic  	oncolytic  	 JJ	B-NP
adenoviruses 	adenoviruses 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
are  	are  	 VBP	O
able  	able  	 JJ	O
to  	to  	 TO	O
infect 	infect 	 VB	O
,  	,  	 ,	O
replicate  	replicate  	 VBG	O
in  	in  	 IN	O
and  	and  	 CC	O
lyse  	lyse  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
Recent  	Recent  	 JJ	O
data  	data  	 NNS	O
from  	from  	 IN	O
clinical  	clinical  	 JJ	B-NP
trials  	trials  	 NNS	I-NP
with  	with  	 IN	O
these  	these  	 DT	O
vectors  	vectors  	 NNS	O
have  	have  	 VBP	O
shown  	shown  	 VBN	O
that  	that  	 IN	O
they  	they  	 PRP	O
are  	are  	 VBP	O
safe 	safe 	 JJ	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
antitumor  	antitumor  	 JJ	B-NP
efficacy  	efficacy  	 NN	I-NP
needs  	needs  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
improved  	improved  	 VBN	O
to  	to  	 TO	O
make  	make  	 VB	O
oncolytic  	oncolytic  	 VBN	O
adenoviruses  	adenoviruses  	 VBG	O
a  	a  	 DT	O
viable  	viable  	 JJ	O
treatment  	treatment  	 NN	B-NP
alternative  	alternative  	 NN	I-NP
for  	for  	 IN	I-NP
cancer  	cancer  	 NN	I-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
This  	This  	 DT	O
review  	review  	 NN	O
focuses  	focuses  	 VBZ	O
on  	on  	 IN	O
targeting  	targeting  	 VBG	B-NP
strategies  	strategies  	 NNS	I-NP
to  	to  	 TO	O
improve  	improve  	 VB	O
tumor  	tumor  	 NN	B-NP
cell  	cell  	 NN	I-NP
transduction  	transduction  	 NNS	I-NP
and  	and  	 CC	O
cancer  	cancer  	 NN	B-NP
cell  	cell  	 NN	I-NP
selective  	selective  	 JJ	I-NP
replication 	replication 	 NN	I-NP
.  	.  	 .	O
Strategies  	Strategies  	 NNS	O
to  	to  	 TO	O
improve  	improve  	 VB	O
antitumor  	antitumor  	 JJ	B-NP
efficacy  	efficacy  	 NN	I-NP
by  	by  	 IN	O
arming  	arming  	 VBG	O
the  	the  	 DT	O
virus  	virus  	 NN	O
with  	with  	 IN	O
therapeutic  	therapeutic  	 JJ	B-NP
transgenes  	transgenes  	 NNS	I-NP
are  	are  	 VBP	O
also  	also  	 RB	O
discussed 	discussed 	 VBN	O
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
an  	an  	 DT	O
overview  	overview  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
most  	most  	 RBS	O
important  	important  	 JJ	O
clinical  	clinical  	 JJ	B-NP
approaches  	approaches  	 NNS	I-NP
with  	with  	 IN	O
oncolytic  	oncolytic  	 JJ	B-NP
adenoviruses  	adenoviruses  	 NN	I-NP
is  	is  	 VBZ	O
given 	given 	 VBN	O
.  	.  	 .	O
